Speaker illustration

Professor Hendrik Bonnemeier

University Medical Center of Schleswig-Holstein, Kiel (Germany)

Renal function worsening in factor-xa inhibitors vs phenprocoumon in patients with non-valvular atrial fibrillation and renal disease - insights from the RELOADED study

Event: ESC CONGRESS 2019

Topic: Oral Anticoagulation

Session: Atrial fibrillation and oral anticoagulation 1

Thumbnail

Are there shock incidence and mortality differences in primary prevention patients regarding device type and ischemia? A NORDIC ICD sub-study.

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Heart failure devices: new approaches

Thumbnail

Comparative effcomparative effectiveness and safety of factor-xa inhibitors vs phenprocoumon in patients with non-valvular atrial fibrillation and malignant diseases, insights from the RELOADED study

Event: ESC CONGRESS 2019

Topic: Oral Anticoagulation

Session: Atrial fibrillation and oral anticoagulation 4

Thumbnail

Comparative safety of factor-xa inhibitors vs phenprocoumon in patients with non-valvular atrial fibrillation and renal disease - insights from the RELOADED study

Event: ESC CONGRESS 2019

Topic: Oral Anticoagulation

Session: Atrial fibrillation and oral anticoagulation 6

Thumbnail

State of the art in cardiac resynchronization therapy: how device features improve clinical outcomes

Event: ESC CONGRESS 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Heart failure in 2019: latest update on implantable device therapy

Thumbnail

Think about the kidneys: why does renal function matter in patients with atrial fibrillation?

Event: ESC CONGRESS 2019

Topic: Stroke Prevention

Session: The bigger picture in stroke prevention and anticoagulation: think beyond atrial fibrillation

Thumbnail

Q&A and closing - Solving the puzzle of heart failure, diabetic kidney disease and risk of stroke: let’s fit the pieces together.

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Cardiovascular Disease in Special Populations

Session: Solving the puzzle of heart failure, diabetic kidney disease and risk of stroke: let’s fit the pieces together

Thumbnail

Interlinked factors affecting stroke risk in your patients with AF.

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Atrial Fibrillation (AF)

Session: Solving the puzzle of heart failure, diabetic kidney disease and risk of stroke: let’s fit the pieces together

Thumbnail

Real-world effectiveness of stroke prevention in patients with non-valvular atrial fibrillation treated with rivaroxaban vs. phenprocoumon in germany - insights from the reload study

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention

Thumbnail

Characteristics of 15mg od rivaroxaban patients from the RELOAD study

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention

Thumbnail

This platform is supported by

logo Novo Nordisk